Skip to main content
SpringerLink
Log in

Gigantism: Management of Fatigue and Daytime Sleepiness After Surgery and Radiation in Adolescents with GH Secreting Adenoma

  • Chapter
  • First Online:
Pituitary Tumors

  • 471 Accesses

Abstract

The management of gigantism requires a multidisciplinary approach. It usually requires surgery, radiation, and/or medical treatment. These therapies may cause panhypopituitarism with or without growth hormone deficiency. Fatigue and altered sleep patterns could result from the disease itself, its treatment, or other psychological factors and demand a systematic approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol. 2014;386(1–2):2–15. https://doi.org/10.1016/j.mce.2013.08.002.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med. 2014;371(25):2363–74. https://doi.org/10.1056/NEJMoa1408028.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Cazabat L, Libe R, Perlemoine K, Rene-Corail F, Burnichon N, Gimenez-Roqueplo AP, et al. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol. 2007;157(1):1–8. https://doi.org/10.1530/EJE-07-0181.

    Article  PubMed  CAS  Google Scholar 

  4. Shimon I, Jallad RS, Fleseriu M, Yedinak CG, Greenman Y, Bronstein MD. Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors. Eur J Endocrinol. 2015;172(6):707–13. https://doi.org/10.1530/EJE-14-1117.

    Article  PubMed  CAS  Google Scholar 

  5. Thapar K, Kovacs KT, Stefaneanu L, Scheithauer BW, Horvath E, Lloyd RV, et al. Antiproliferative effect of the somatostatin analogue octreotide on growth hormone-producing pituitary tumors: results of a multicenter randomized trial. Mayo Clin Proc. 1997;72(10):893–900. https://doi.org/10.1016/S0025-6196(11)63358-2.

    Article  PubMed  CAS  Google Scholar 

  6. Freda PU. Somatostatin analogs in acromegaly. J Clin Endocrinol Metab. 2002;87(7):3013–8. https://doi.org/10.1210/jcem.87.7.8665.

    Article  PubMed  CAS  Google Scholar 

  7. Buhk JH, Jung S, Psychogios MN, Goricke S, Hartz S, Schulz-Heise S, et al. Tumor volume of growth hormone-secreting pituitary adenomas during treatment with pegvisomant: a prospective multicenter study. J Clin Endocrinol Metab. 2010;95(2):552–8. https://doi.org/10.1210/jc.2009-1239.

    Article  PubMed  CAS  Google Scholar 

  8. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol. 1994;40(1):111–6.

    Article  CAS  Google Scholar 

  9. Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, et al. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab. 2010;95(2):567–77. https://doi.org/10.1210/jc.2009-1611.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Dempsey OJ, McGeoch P, de Silva RN, Douglas NJ. Acquired narcolepsy in an acromegalic patient who underwent pituitary irradiation. Neurology. 2003;61(4):537–40.

    Article  PubMed  Google Scholar 

  11. Murrant NJ, Gatland DJ. Respiratory problems in acromegaly. J Laryngol Otol. 1990;104(1):52–5.

    Article  CAS  PubMed  Google Scholar 

  12. Benfante A, Ciresi A, Bellia M, Cannizzaro F, Bellia V, Giordano C, et al. Early lung function abnormalities in acromegaly. Lung. 2015;193(3):393–9. https://doi.org/10.1007/s00408-015-9710-1.

    Article  PubMed  CAS  Google Scholar 

  13. Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, et al. Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J Clin Endocrinol Metab. 2010;95(12):E392–402. https://doi.org/10.1210/jc.2010-1253.

    Article  PubMed  CAS  Google Scholar 

  14. Ryan J. Radiation somnolence syndrome. J Pediatr Oncol Nurs. 2000;17(1):50–3.

    Article  CAS  PubMed  Google Scholar 

  15. Postma MR, Netea-Maier RT, van den Berg G, Homan J, Sluiter WJ, Wagenmakers MA, et al. Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur J Endocrinol. 2012;166(4):585–92. https://doi.org/10.1530/EJE-11-0853.

    Article  PubMed  CAS  Google Scholar 

  16. Khairi S, Sagvand BT, Pulaski-Liebert K, Tritos NA, Klibanski A, Nachtigall LB. Clinical Outcomes and Self-Reported Symptoms in patients with Acromegaly: An 8-Year Follow-up of a Lanreotide Study. Endocr Pract. 2017;23:56–65.

    Google Scholar 

  17. Webster J, Piscitelli G, Polli A, D’Alberton A, Falsetti L, Ferrari C, et al. The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group. Clin Endocrinol. 1993;39(3):323–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Endocrinology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Vibha Singhal

Authors
  1. Vibha Singhal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vibha Singhal .

Editor information

Editors and Affiliations

  1. Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Lisa B. Nachtigall

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Singhal, V. (2018). Gigantism: Management of Fatigue and Daytime Sleepiness After Surgery and Radiation in Adolescents with GH Secreting Adenoma. In: Nachtigall, L. (eds) Pituitary Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-90909-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90909-7_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90907-3

  • Online ISBN: 978-3-319-90909-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation